Hilltop Partners’s Elevance Health ELV Stock Holding History

Hilltop Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$268K	Buy	914 +45	+5%	+$14.8K	0.07%	104
2025 Q4	$305K	Hold	869	–	–	0.08%	94
2025 Q3	$281K	Hold	869	–	–	0.08%	95
2025 Q2	$338K	Buy	869 +40	+5%	+$16.1K	0.1%	84
2025 Q1	$361K	Buy	829 +3	+0.4%	+$1.2K	0.12%	78
2024 Q4	$305K	Hold	826	–	–	0.1%	80
2024 Q3	$430K	Sell	826 -70	-8%	-$37.4K	0.14%	73
2024 Q2	$486K	Hold	896	–	–	0.18%	66
2024 Q1	$465K	Sell	896 -4	-0.4%	-$1.99K	0.17%	70
2023 Q4	$424K	Buy	900 +9	+1%	+$4.16K	0.17%	68
2023 Q3	$388K	Hold	891	–	–	0.16%	69
2023 Q2	$396K	Buy	891 +7	+0.8%	+$3.23K	0.16%	66
2023 Q1	$406K	Hold	884	–	–	0.18%	47
2022 Q4	$453K	Buy	+884	New	+$449K	0.24%	32

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Hilltop Partners's ELV Position: Q1 2026 in Review

Hilltop Partners increased its Elevance Health (ELV) stake by 5.2% in Q1 2026, buying an estimated $14.8K and bringing the position to 914 shares worth $268K. The position accounts for 0.07% of the portfolio, ranked #104.

Hilltop Partners first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. The position peaked at $486K in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Hilltop Partners held 914 shares of Elevance Health worth $268K as of Q1 2026.
Hilltop Partners bought 45 Elevance Health shares in Q1 2026, an estimated $14.8K.
Elevance Health made up 0.07% of Hilltop Partners's portfolio in Q1 2026, its #104 holding.
Hilltop Partners first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
Hilltop Partners's Elevance Health position peaked at $486K in Q2 2024.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Hilltop Partners's 13F filing for Q1 2026, filed 12 May 2026.